Notice of Participation in PAR-18-721 "Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed)

Notice Number: NOT-NS-18-053

Key Dates
Release Date: March 29, 2018

Related Announcements
PAR-18-721

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
National Eye Institute (NEI)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)

Purpose

The purpose of this Notice is to inform potential applicants that the National Eye Institute (NEI),  National Institute of Environmental Health Sciences (NIEHS), and the National Institute on Drug Abuse (NIDA) are participating in PAR-18-721 "Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed).

The following sections have been updated to reflect the participation of NINDS in this FOA.

Currently Reads:
Part 1. Overview Information
Components of Participating Organizations
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.853; 93.846

Modified to Read:
Part 1. Overview Information
Components of Participating Organizations

National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Eye Institute (NEI)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)

 

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.853; 93.846; 93.867; 93.279; 93.113


The following contacts have been added:

Section VII. Agency Contacts

Scientific/Research Contact(s)

For questions related to ocular injury research: 
Houmam Araj, Ph.D.
National Eye Institute (NEI)
Telephone: 301-451-2020
Email: arajh@nei.nih.gov

For questions related to pulmonary injury research:
Srikanth S. Nadadur, Ph.D.
National Institute of Environmental Health Sciences (NIEHS)
Telephone: 919-541-5327
Email: nadadurs@niehs.nih.gov

For questions related to pharmaceutical based agents:
Kristopher Bough, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-9800
Email: boughk@nih.gov

Financial/Grants Management Contact(s)

Karen Robinson Smith
National Eye Institute (NEI)
Telephone: 301-451-2020
Email: kyr@nei.nih.gov

Lisa A. Edwards, MBA
National Institute of Environmental Health Sciences (NIEHS)
Telephone:  919-541-0751
E-mail: archer@niehs.nih.gov

Amy Connolly
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-4457
Email: connolla@mail.nih.gov

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Shardell Spriggs, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-443-8189
Email: shardell.spriggs@nih.gov